Yamarthi, P.; Kotipalli, R.S.; Patnaik, S.; Veena, K.; Kathirvel, M.; Vutukuri, R.; Bhanoori, M.
Correction: Yamarthi et al. Sepia pharaonis Ink Mitigates Dehydroepiandrosterone-Induced Insulin Resistance in Mouse Model of Polycystic Ovarian Syndrome. Pathophysiology 2024, 31, 408–419. Pathophysiology 2025, 32, 4.
https://doi.org/10.3390/pathophysiology32010004
AMA Style
Yamarthi P, Kotipalli RS, Patnaik S, Veena K, Kathirvel M, Vutukuri R, Bhanoori M.
Correction: Yamarthi et al. Sepia pharaonis Ink Mitigates Dehydroepiandrosterone-Induced Insulin Resistance in Mouse Model of Polycystic Ovarian Syndrome. Pathophysiology 2024, 31, 408–419. Pathophysiology. 2025; 32(1):4.
https://doi.org/10.3390/pathophysiology32010004
Chicago/Turabian Style
Yamarthi, Prathyusha, Rama Satyasri Kotipalli, Samatasai Patnaik, Kv Veena, Muralidharan Kathirvel, Rajkumar Vutukuri, and Manjula Bhanoori.
2025. "Correction: Yamarthi et al. Sepia pharaonis Ink Mitigates Dehydroepiandrosterone-Induced Insulin Resistance in Mouse Model of Polycystic Ovarian Syndrome. Pathophysiology 2024, 31, 408–419" Pathophysiology 32, no. 1: 4.
https://doi.org/10.3390/pathophysiology32010004
APA Style
Yamarthi, P., Kotipalli, R. S., Patnaik, S., Veena, K., Kathirvel, M., Vutukuri, R., & Bhanoori, M.
(2025). Correction: Yamarthi et al. Sepia pharaonis Ink Mitigates Dehydroepiandrosterone-Induced Insulin Resistance in Mouse Model of Polycystic Ovarian Syndrome. Pathophysiology 2024, 31, 408–419. Pathophysiology, 32(1), 4.
https://doi.org/10.3390/pathophysiology32010004
